NorthSea Therapeutics Completes US$80 Million Series C Fundraising co-led by Ysios Capital to Advance Clinical Programs in Metabolic Disorders

by Ysios Capital

The financing round was co-led by Ysios Capital and Forbion Growth and joined by new investors; a large managed care organization, and Hercules Capital, Inc. Existing investors Forbion Ventures, venBi...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Nzyme, respaldado por Kibo y Oliver Wyma...

by Kibo Ventures

Nzyme, el fondo de Private Equity, ha anunciado su segunda inversión ...

Photos Stream